Delivery Order SPE2DB22D3301-SPE2DB24FY9ET
Award Date
6/25/24
Potential Completion Date
7/17/24
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of IMBRUVICA 420 MG TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract is a Delivery Order with a Firm Fixed Price type, valued at $7,322.67, and has a period of performance through July 17, 2024. The contract was awarded on June 25, 2024 and does not have a set-aside designation. Amerisourcebergen, a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of IMBRUVICA 140 MG TABLET 28S, a pharmaceutical product. The contract, awarded by the Defense Logistics Agency (DLA), a defense agency, has a ceiling value of $7,322.67 and an ultimate completion date of July 12, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation. Amerisourcebergen, a major supplier of...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of IMBRUVICA 420 MG TABLET 28S. The award, valued at $7,575.75, is a firm fixed-price contract with a completion date of December 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 Firm Fixed Price Delivery Order contract is for the provision of the drug IMBRUVICA 280 MG TABLET 28S. The contract has an ultimate completion date of March 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,322.67 firm fixed-price contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has an ultimate completion date of August 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order placed by the Defense Logistics Agency (DLA) for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a firm fixed price of $7,322.67 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense under an indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of IMBRUVICA 420 MG TABLET 28S. The fixed-price contract has a ceiling value of $37,878.75 and a performance period through July 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug IMBRUVICA 420 MG TABLET 28S to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $43,936.02 firm-fixed price delivery order has a completion date of July 17, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,575.75 firm-fixed-price contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a medication. The contract has a period of performance through June 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, involves the delivery of IMBRUVICA 140 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $23,537.16, has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...